The human genome is under continuous selective pressure for resistance to infectious diseases. Several polymorphic alleles have been associated with resistance to malaria in West African populations, for example. In the November 15 Nature, David Modiano and colleagues report a large-scale study aimed at clarifying the role of hemoglobin C (HbC) in resistance to Plasmodiumfalciparum malaria (Nature 2001, 414:305-308).

Modiano et al. evaluated allele frequencies for the β globin gene in 3,513 healthy subjects and 835 malaria patients in Burkina Faso. The results show that HbC can provide protection against P. falciparum malaria in both the heterozygous and homozygous states. The reduced risk is 93% for HbCC homozygosity and 29% for HbAC heterozygosity.

The authors predict that the HbC alleles will spread across Africa, replacing the sickle hemoglobin (hemoglobin S; HbS) polymorphisms that are associated with reduced fitness.

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Join for free todayAlready a member?Login Here